Altundag K. Late relapse rates in patients with early-stage hormone receptor-positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy. J Surg Oncol 2020 Feb 17. doi: 10.1002/jso.25857.
PMID: 32067243